|
1
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening, and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malfertheiner P, Megraud F, O'Morain CA,
Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton
J, Graham DY, et al: Management of Helicobacter pylori
infection-the maastricht V/florence consensus report. Gut. 66:6–30.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Graham DY: Helicobacter pylori
update: Gastric cancer, reliable therapy, and possible benefits.
Gastroenterology. 148:719–731.e3. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watanabe T, Takahashi A, Suzuki K,
Kurusu-Kanno M, Yamaguchi K, Fujiki H and Suganuma M:
Epithelial-mesenchymal transition in human gastric cancer cell
lines induced by TNF-α-inducing protein of Helicobacter
pylori. Int J Cancer. 134:2373–2382. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi YJ, Kim N, Chang H, Lee HS, Park SM,
Park JH, Shin CM, Kim JM, Kim JS, Lee DH and Jung HC:
Helicobacter pylori-induced epithelial-mesenchymal
transition, a potential role of gastric cancer initiation and an
emergence of stem cells. Carcinogenesis. 36:553–563. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li N, Feng Y, Hu Y, He C, Xie C, Ouyang Y,
Artim SC, Huang D, Zhu Y, Luo Z, et al: Helicobacter pylori
CagA promotes epithelial mesenchymal transition in gastric
carcinogenesis via triggering oncogenic YAP pathway. J Exp Clin
Cancer Res. 37:2802018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong SHM, Fang CM, Chuah LH, Leong CO and
Ngai SC: E-cadherin: Its dysregulation in carcinogenesis and
clinical implications. Crit Rev Oncol Hematol. 121:11–22. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ye X and Weinberg RA:
Epithelial-mesenchymal plasticity: A central regulator of cancer
progression. Trends Cell Biol. 25:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu W, Yang Z and Lu N: A new role for the
PI3K/Akt signaling pathway in the epithelial-mesenchymal
transition. Cell Adh Migr. 9:317–324. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Warfel NA and Kraft AS: PIM kinase (and
Akt) biology and signaling in tumors. Pharmacol Ther. 151:41–49.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beurel E, Grieco SF and Jope RS: Glycogen
synthase kinase-3 (GSK3): Regulation, actions, and diseases.
Pharmacol Ther. 148:114–131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Katoh M and Katoh M: Cross-talk of WNT and
FGF signaling pathways at GSK3beta to regulate beta-catenin and
SNAIL signaling cascades. Cancer Biol Ther. 5:1059–1064. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shu X, Yang Z, Li ZH, Chen L, Zhou XD, Xie
Y and Lu NH: Helicobacter pylori Infection activates the
akt-Mdm2-p53 signaling pathway in gastric epithelial cells. Dig Dis
Sci. 60:876–886. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang Z, Xie C, Xu W, Liu G, Cao X, Li W,
Chen J, Zhu Y, Luo S, Luo Z and Lu N: Phosphorylation and
inactivation of PTEN at residues Ser380/Thr382/383 induced by
Helicobacter pylori promotes gastric epithelial cell
survival through PI3K/Akt pathway. Oncotarget. 6:31916–31926. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hamilton SR and Aaltonen LA: Pathology and
genetics of tumours of the digestive system. IARC Press; Lyon:
2000
|
|
20
|
Dixon MF, Genta RM, Yardley JH and Correa
P: Classification and grading of gastritis. The updated sydney
system. International workshop on the histopathology of gastritis,
houston 1994. Am J Surg Pathol. 20:1161–1181. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ
and Lu NH: Reduced expression of PTEN and increased PTEN
phosphorylation at residue Ser380 in gastric cancer tissues: A
novel mechanism of PTEN inactivation. Clin Res Hepatol
Gastroenterol. 37:72–79. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu W, Huang Y, Yang Z, Hu Y, Shu X, Xie C,
He C, Zhu Y and Lu N: Helicobacter pylori promotes gastric
epithelial cell survival through the PLK1/PI3K/Akt pathway. Onco
Targets Ther. 11:5703–5713. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Suerbaum S and Michetti P: Helicobacter
pylori infection. N Engl J Med. 347:1175–1186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naumann M, Sokolova O, Tegtmeyer N and
Backert S: Helicobacter pylori: A paradigm pathogen for
subverting host cell signal transmission. Trends Microbiol.
25:316–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun GY, Wu JX, Wu JS, Pan YT and Jin R:
Caveolin-1, E-cadherin and β-catenin in gastric carcinoma,
precancerous tissues and chronic non-atrophic gastritis. Chin J
Cancer Res. 24:23–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sheng S, Qiao M and Pardee AB: Metastasis
and AKT activation. J Cell Physiol. 218:451–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiao M, Sheng S and Pardee AB: Metastasis
and AKT activation. Cell Cycle. 7:2991–2996. 2008. View Article : Google Scholar : PubMed/NCBI
|